ZA200703166B - Composition comprising lactic acid and lactoferrin - Google Patents

Composition comprising lactic acid and lactoferrin

Info

Publication number: ZA200703166B
Authority: ZA; South Africa
Prior art keywords: composition; lactoferrin; lactic acid; treatment; prophylaxis
Prior art date: 2004-06-23

Application number

ZA200703166A

Other languages

English (en)

Inventor

Bjoern Andersch

Inger Mattsby-Baltzer

Original Assignee

Nestor Medical Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-23

Filing date

2005-06-23

Publication date

2008-08-27

2005-06-23 Application filed by Nestor Medical Ab filed Critical Nestor Medical Ab

2008-08-27 Publication of ZA200703166B publication Critical patent/ZA200703166B/xx

Links

JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title abstract 4
102000010445 Lactoferrin Human genes 0.000 title abstract 2
108010063045 Lactoferrin Proteins 0.000 title abstract 2
CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 title abstract 2
235000014655 lactic acid Nutrition 0.000 title abstract 2
239000004310 lactic acid Substances 0.000 title abstract 2
229940078795 lactoferrin Drugs 0.000 title abstract 2
235000021242 lactoferrin Nutrition 0.000 title abstract 2
238000011282 treatment Methods 0.000 abstract 3
238000011321 prophylaxis Methods 0.000 abstract 2
108010033276 Peptide Fragments Proteins 0.000 abstract 1
102000007079 Peptide Fragments Human genes 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gynecology & Obstetrics (AREA)
Urology & Nephrology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

ZA200703166A 2004-06-23 2005-06-23 Composition comprising lactic acid and lactoferrin ZA200703166B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE0401631A SE528337C2 (sv)	2004-06-23	2004-06-23	Sammansättning innefattande mjölksyra och laktoferrin, eller ett peptidfragment därav, och användning av denna sammansättning för behandling av tillstånd i urogenitalsystemet

Publications (1)

Publication Number	Publication Date
ZA200703166B true ZA200703166B (en)	2008-08-27

Family

ID=32768753

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200703166A ZA200703166B (en)	2004-06-23	2005-06-23	Composition comprising lactic acid and lactoferrin

Country Status (15)

Country	Link
US (1)	US20080161234A1 (xx)
EP (1)	EP1784176B1 (xx)
JP (1)	JP2008503576A (xx)
KR (1)	KR20070048170A (xx)
CN (1)	CN1972683A (xx)
AT (1)	ATE464045T1 (xx)
AU (1)	AU2005257722B2 (xx)
BR (1)	BRPI0512503A (xx)
CA (1)	CA2571183A1 (xx)
DE (1)	DE602005020639D1 (xx)
NZ (1)	NZ552764A (xx)
RU (1)	RU2398575C2 (xx)
SE (1)	SE528337C2 (xx)
WO (1)	WO2006001766A1 (xx)
ZA (1)	ZA200703166B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100801891B1 (ko) *	2006-11-02	2008-02-12	한상진	천연물질을 이용한 생식기 염증 예방 또는 치료용 약제학적 조성물
EP2679222A1 (en) *	2007-03-30	2014-01-01	Laccure Ab	Use of oligomers of lactic acid in the treatment of gynaecological infections
EP2130531A1 (en) *	2008-06-04	2009-12-09	Rolf Kullgren AB	Vaginal suppository comprising lactic acid
SG171444A1 (en) *	2009-01-23	2011-07-28	Acraf	Controlled release pharmaceutical or food formulation and process for its preparation
KR101133723B1 (ko) *	2009-10-19	2012-04-09	최원석	소금 및 당을 유효성분으로 함유하는 질염 예방 및 치료용 조성물 및 이의 용도
US9011909B2 (en)	2010-09-03	2015-04-21	Wisconsin Pharmacal Company, Llc	Prebiotic suppositories
EP2872117B1 (en) *	2012-07-16	2017-09-27	Laccure Ab	Pharmaceutical compositions containing oligomeric lactic acid
ITMI20122152A1 (it) *	2012-12-17	2014-06-18	Progine Farmaceutici S R L	Composizione per uso topico.
EP2992894A1 (en) *	2014-09-05	2016-03-09	Progine Farmaceutici Srl	Vaginal formulations for preventing and treating vaginal and cervico-vaginal infections
RU2637649C2 (ru) *	2014-10-30	2017-12-05	Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский Томский государственный университет" (ТГУ, НИ ТГУ)	Способ и реагент-индикатор для рН-метрии вагинальной жидкости
MX2017016991A (es) *	2017-12-20	2019-06-21	Centro De Retina Medica Y Quirurgica S C	Formulación para la administración oral de extracto de arándano azul como auxiliar en la conservación de la salud de la película lagrimal en seres humanos.
KR102683248B1 (ko)	2021-11-10	2024-07-10	장효영	질염 예방 및 치료를 위한 주입형 질 유산균 조성물
EP4260869A1 (en) *	2022-04-11	2023-10-18	Reckitt Benckiser Health Limited	Composition comprising a combination of lactoferrin and a sulphated polysaccharide

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE8603338D0 (sv) *	1986-08-07	1986-08-07	Bjorn Andersch	Medel for behandling av tillstand i slidan
DE69220679T2 (de) *	1992-01-23	1997-10-23	Morinaga Milk Industry Co. Ltd., Tokio/Tokyo	Antibakterielles mittel und behandlung von gegenständen mit diesem
EP0920331A1 (en) *	1996-08-12	1999-06-09	A+ Science Invest AB	Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin
US6240320B1 (en) *	1998-06-05	2001-05-29	Intermedics Inc.	Cardiac lead with zone insulated electrodes
CA2334370A1 (en) *	1998-06-05	1999-12-16	Nobuyuki Suzuki	Lactic acid bacterium-containing compositions, drugs and foods
JP3439686B2 (ja) *	1999-03-30	2003-08-25	雪印乳業株式会社	鉄強化飲料
IT1317937B1 (it) *	2000-11-17	2003-07-15	Sigma Tau Healthscience Spa	Composizione per stimolare le difese immunitarie ed il metabolismo delferro comprendente una alcanoil l-carnitina e lattoferrina.

2004
- 2004-06-23 SE SE0401631A patent/SE528337C2/sv not_active IP Right Cessation
2005
- 2005-06-23 NZ NZ552764A patent/NZ552764A/en not_active IP Right Cessation
- 2005-06-23 KR KR1020077001696A patent/KR20070048170A/ko not_active Withdrawn
- 2005-06-23 JP JP2007518008A patent/JP2008503576A/ja not_active Abandoned
- 2005-06-23 AT AT05755054T patent/ATE464045T1/de not_active IP Right Cessation
- 2005-06-23 AU AU2005257722A patent/AU2005257722B2/en not_active Ceased
- 2005-06-23 CN CNA2005800206978A patent/CN1972683A/zh active Pending
- 2005-06-23 RU RU2007102273/15A patent/RU2398575C2/ru not_active IP Right Cessation
- 2005-06-23 EP EP05755054A patent/EP1784176B1/en not_active Expired - Lifetime
- 2005-06-23 DE DE602005020639T patent/DE602005020639D1/de not_active Expired - Lifetime
- 2005-06-23 CA CA002571183A patent/CA2571183A1/en not_active Abandoned
- 2005-06-23 US US11/628,664 patent/US20080161234A1/en not_active Abandoned
- 2005-06-23 WO PCT/SE2005/000989 patent/WO2006001766A1/en not_active Ceased
- 2005-06-23 ZA ZA200703166A patent/ZA200703166B/xx unknown
- 2005-06-23 BR BRPI0512503-0A patent/BRPI0512503A/pt not_active IP Right Cessation

Also Published As

Publication number	Publication date
SE0401631D0 (sv)	2004-06-23
US20080161234A1 (en)	2008-07-03
NZ552764A (en)	2010-03-26
ATE464045T1 (de)	2010-04-15
SE0401631L (sv)	2005-12-24
AU2005257722A1 (en)	2006-01-05
RU2398575C2 (ru)	2010-09-10
RU2007102273A (ru)	2008-07-27
CA2571183A1 (en)	2006-01-05
AU2005257722B2 (en)	2009-03-12
BRPI0512503A (pt)	2008-03-11
KR20070048170A (ko)	2007-05-08
EP1784176B1 (en)	2010-04-14
CN1972683A (zh)	2007-05-30
SE528337C2 (sv)	2006-10-24
JP2008503576A (ja)	2008-02-07
WO2006001766A1 (en)	2006-01-05
EP1784176A1 (en)	2007-05-16
DE602005020639D1 (de)	2010-05-27

Publication	Publication Date	Title
UA90048C2 (ru)	2010-03-25	Кондиционированная композиция и способ ее получения
EP2508178A3 (en)	2018-01-03	Use of nutritional compositions for preventing disorders
ATE551063T1 (de)	2012-04-15	Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen
MX2010002498A (es)	2010-03-26	Metodos para tratar o prevenir la infeccion del tracto respiratorio que comprende la administracion de colecalciferol.
SG163600A1 (en)	2010-08-30	Methods for the treatment of muscle loss
NZ707292A (en)	2017-06-30	Activin-actrii antagonists and uses for increasing red blood cell levels
NZ594814A (en)	2013-03-28	Peptide that is derived from a milk protein and has an antioxidative effect and also acts as a blood adiponectin level increase promotion and/or decrease inhibition agent
ZA200703166B (en)	2008-08-27	Composition comprising lactic acid and lactoferrin
EP1670450B8 (en)	2011-03-23	Pharmaceutical compositions and method of using levodopa and carbidopa
WO2006013441A3 (en)	2006-04-06	Use of probiotic bacteria for the preparation of topical compositions for skin protection
MY138708A (en)	2009-07-31	Biaryloxymethylarenecarboxylic acids
WO2007143607A3 (en)	2008-02-21	Method of treating atrophic vaginitis
WO2007082068A3 (en)	2008-07-31	Methods and compositions for treating asthma in human and non human primates
WO2007025977A3 (en)	2007-06-07	Anti-tnf alpha producing lactic acid bacteria for the treatment of chronic enterocolitis
WO2008079270A3 (en)	2008-10-16	Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
MXPA04005346A (es)	2004-09-27	Uso de microorganismos para una distribucion dirigida de sustancias a partes especificas del intestino.
WO2011075606A3 (en)	2011-11-03	Hyperglycosylated polypeptide variants and methods of use
WO2007002836A3 (en)	2008-09-12	Methods and compositions for the prevention and treatment of kidney disease
WO2006135493A3 (en)	2007-03-15	A composition for wound healing and use thereof
IL194353A0 (en)	2011-08-01	Lysobactin amides
WO2005110413A3 (en)	2006-07-13	Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions
WO2006047470A3 (en)	2006-06-22	Compositions containing malva sylvestris extract and use thereof on skin or mucosal tissues
WO2007097810A3 (en)	2007-11-29	Treatment for antiphospholipid-syndrome-related pregnancy complications
WO2007084964A3 (en)	2007-12-27	Pharmaceutical composition comprising a protein pump inhibitor and protein component
IL182297A0 (en)	2008-04-13	The use of winter savory (satureja montana) or the extracts thereof for the preparation of medicaments for the treatment of the premature ejaculation